EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Coupling Immunoprecipitation with Multiplexed Digital PCR for Cell-Free DNA Methylation Detection in Small Plasma Volumes of Early-Onset Colorectal Cancer

Truong T Truong iD, Klara Mikloska, Judith Sum, Martina Oberländer, Nikolas von Bubnoff, Lea Christiansen, Sebastian Tornow, Stefanie Derer, Florian Janke, Holger Sültmann, Sebastian Zeissig, Michael Linnebacher und 5 weitere

Analytical Chemistry · 2025

DOI: 10.1021/acs.analchem.5c01361 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Chemistry, 2025. Verfasst von Truong T Truong und 16 weiteren Autor:innen. Beteiligte Einrichtung: Hahn-Schickard, 79110 Freiburg, Germany. Hauptthemen laut MEDLINE: Colorectal Neoplasms, DNA Methylation, Immunoprecipitation, Multiplex Polymerase Chain Reaction. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium f?r Bildung und Forschung, Bundesministerium f?r Wirtschaft und Klimaschutz, Mertelsmann Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) remains a major global health challenge, with an increasing incidence of early-onset cases among young adults. Targeted analysis of cell-free DNA (cfDNA) methylation in blood has emerged as a promising minimally invasive diagnostic approach. While digital PCR (dPCR) offers high sensitivity and low turnaround times, conventional bisulfite-based dPCR assays require large plasma volumes due to cfDNA degradation, limiting clinical feasibility. To overcome this limitation, we developed a bisulfite-free, low-plasma-volume assay by coupling cell-free methylated DNA immunoprecipitation (cfMeDIP) with multiplexed dPCR for methylation detection. Assays were designed for CRC targets based on publicly available bisulfite-based plasma data and optimized for native, bisulfite-untreated cfDNA. The cfMeDIP-dPCR assays were first developed and optimized on circulating tumor DNA surrogates derived from HCT116 cells and subsequently validated in a pilot study, including 32 early-onset CRC (EO-CRC) patients and 29 non-CRC individuals. Methylation ratios, defined as the proportion of methylated to total cfDNA copies per marker, served as a diagnostic indicator. Three out of four selected markers (SEPT9, KCNQ5, and C9orf50) were successfully adapted, with significantly higher methylation ratios (p ≤ 0.001) in the EO-CRC cohort. KCNQ5 demonstrated the highest diagnostic performance, achieving an 85% sensitivity at a 90% specificity, with methylation ratios correlating with the tumor stage. This study presents the first cfMeDIP-dPCR approach, demonstrating its potential as a sensitive liquid biopsy assay. Requiring only 0.5 mL of plasma, i.e., more than 20 times less than a sensitivity-matched bisulfite-based assay, cfMeDIP-dPCR facilitates clinical implementation for CRC and other diseases with epigenetic signatures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsDNA MethylationImmunoprecipitationMultiplex Polymerase Chain ReactionCell-Free Nucleic AcidsHumansSeptinsBiomarkers, TumorHCT116 CellsFemaleMale

Substanzen

Cell-Free Nucleic AcidsSeptinsBiomarkers, TumorSEPTIN9 protein, human

Autor:innen und Institutionen

  • Hahn-Schickard, 79110 Freiburg, Germany.
  • Laboratory for MEMS Applications, IMTEK─Department of Microsystems Engineering, University of Freiburg, 79110 Freiburg, Germany.
  • Interdisciplinary Center for Biobanking-Lübeck (ICB-L), University Medical Center Schleswig-Holstein, 23562 Lübeck, Germany.
  • Department of Hematology and Oncology, University Medical Center Schleswig-Holstein, 23538 Lübeck, Germany.
  • European Liquid Biopsy Society (ELBS), 20246 Hamburg, Germany.
  • Institute of Nutritional Medicine, University Medical Center Schleswig-Holstein, 23562 Lübeck, Germany.

ORCID-Profile: Truong T Truong

Förderung

  • Bundesministerium f?r Bildung und Forschung
  • Bundesministerium f?r Wirtschaft und Klimaschutz
  • Mertelsmann Foundation

Zitieren

APA

Truong, T. T., Mikloska, K., Sum, J., Oberländer, M., von Bubnoff, N., Christiansen, L., Tornow, S., Derer, S., Janke, F., Sültmann, H., Zeissig, S., Linnebacher, M., Schafmayer, C., Lehnert, M., Hutzenlaub, T., Paust, N., & Juelg, P. (2025). Coupling Immunoprecipitation with Multiplexed Digital PCR for Cell-Free DNA Methylation Detection in Small Plasma Volumes of Early-Onset Colorectal Cancer. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.5c01361

Vancouver

Truong TT, Mikloska K, Sum J, Oberländer M, von Bubnoff N, Christiansen L, et al. Coupling Immunoprecipitation with Multiplexed Digital PCR for Cell-Free DNA Methylation Detection in Small Plasma Volumes of Early-Onset Colorectal Cancer. Analytical Chemistry. 2025. doi:10.1021/acs.analchem.5c01361

BibTeX
@article{Truong2025,
  author = {Truong, Truong T and Mikloska, Klara and Sum, Judith and Oberländer, Martina and von Bubnoff, Nikolas and Christiansen, Lea and Tornow, Sebastian and Derer, Stefanie and Janke, Florian and Sültmann, Holger and Zeissig, Sebastian and Linnebacher, Michael and Schafmayer, Clemens and Lehnert, Michael and Hutzenlaub, Tobias and Paust, Nils and Juelg, Peter},
  title = {Coupling Immunoprecipitation with Multiplexed Digital PCR for Cell-Free DNA Methylation Detection in Small Plasma Volumes of Early-Onset Colorectal Cancer},
  journal = {Analytical Chemistry},
  year = {2025},
  doi = {10.1021/acs.analchem.5c01361}
}
Kostenlos starten →